InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

FATE THERAPEUTICS INC

FATE Clue Score25
United States Fiscal year ends December CIK 0001434316 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

98
Insider
Date
Role
Action
Shares
Price
Amount
Kamal Adawi
3 Nov 2026
Chief Financial Officer
Sell
6,582
$2.05
$13.52K
Bahram Valamehr
4 Aug 2026
President and CEO
Sell
43,947
$2.46
$108.10K
Cindy Tahl
4 Aug 2026
See Remarks
Sell
38,800
$2.46
$95.41K
Bahram Valamehr
20 May 2026
President and CEO
Sell
28,946
$1.88
$54.48K
Cindy Tahl
20 May 2026
See Remarks
Sell
25,590
$1.88
$48.08K
Bahram Valamehr
9 Jan 2026
President and CEO
Sell
5,190
$1.07
$5.56K
Cindy Tahl
9 Jan 2026
See Remarks
Sell
10,589
$1.06
$11.28K
Bahram Valamehr
4 Aug 2025
President and CEO
Sell
14,466
$1.06
$15.40K
Cindy Tahl
4 Aug 2025
See Remarks
Sell
9,037
$1.06
$9.57K
Bahram Valamehr
10 Jan 2025
President and CEO
Sell
8,705
$1.54
$13.41K
Cindy Tahl
10 Jan 2025
See Remarks
Sell
5,654
$1.55
$8.76K
Jerome Charles Bressi
10 Jan 2025
See Remarks
Sell
5,980
$1.55
$9.27K
Redmile Group, LLC
20 Dec 2024
Director
Sell indirect
341,633
$1.68
$573.94K
Edward J Dulac III
9 Jan 2024
Chief Financial Officer
Sell
7,028
$4.37
$30.71K
J Scott Wolchko
9 Jan 2024
President and CEO
Sell
14,391
$4.37
$62.89K
Bahram Valamehr
9 Jan 2024
Chief R&D Officer
Sell
11,271
$4.38
$49.37K
Cindy Tahl
9 Jan 2024
General Counsel and Secretary
Sell
10,874
$4.37
$47.52K
Edward J Dulac III
18 Aug 2023
Chief Financial Officer
Sell
4,718
$2.80
$13.21K
Brian T. Powl
5 Jul 2023
Chief Commercial Officer
Sell
3,854
$4.87
$18.77K
Redmile Group, LLC
14 Apr 2023
Director
Sell indirect
302,339
$5.84
$1.77M
Yu-Waye Chu
10 Jan 2023
Chief Medical Officer
Sell
7,825
$5.24
$41.00K
Edward J Dulac III
10 Jan 2023
Chief Financial Officer
Sell
7,331
$5.24
$38.41K
Mark Plavsic
10 Jan 2023
Chief Technical Officer
Sell
3,418
$5.24
$17.91K
Cindy Tahl
10 Jan 2023
General Counsel and Secretary
Sell
11,553
$5.24
$60.54K
Bahram Valamehr
10 Jan 2023
Chief R&D Officer
Sell
10,917
$5.24
$57.21K
J Scott Wolchko
10 Jan 2023
President and CEO
Sell
45,907
$5.24
$240.55K
Edward J Dulac III
18 Aug 2022
Chief Financial Officer
Sell
432
$30.41
$13.14K
Edward J Dulac III
18 Aug 2022
Chief Financial Officer
Sell
4,703
$29.75
$139.91K
Mark Plavsic
5 Jul 2022
Chief Technical Officer
Sell
3,719
$24.61
$91.52K
Shefali Agarwal
7 Jun 2022
Director
Sell
841
$21.89
$18.41K
Shefali Agarwal
3 Jun 2022
Director
Sell
807
$22.80
$18.40K
Timothy Coughlin
3 Jun 2022
Director
Sell
1,439
$22.81
$32.82K
Robert Hershberg
3 Jun 2022
Director
Sell
672
$22.75
$15.29K
Karin Jooss
3 Jun 2022
Director
Sell
1,483
$22.82
$33.84K
John Mendlein
3 Jun 2022
Director
Sell
1,364
$22.79
$31.09K
Yu-Waye Chu
19 Apr 2022
Chief Medical Officer
Sell
4,062
$35.37
$143.67K
Yu-Waye Chu
11 Jan 2022
Senior VP Clinical Development
Sell
418
$49.10
$20.52K
Yu-Waye Chu
11 Jan 2022
Senior VP Clinical Development
Sell
3,547
$48.44
$171.82K
Edward J Dulac III
11 Jan 2022
Chief Financial Officer
Sell
390
$49.16
$19.17K
Edward J Dulac III
11 Jan 2022
Chief Financial Officer
Sell
1,380
$48.25
$66.59K
Bahram Valamehr
11 Jan 2022
Chief R&D Officer
Sell
418
$49.12
$20.53K
Bahram Valamehr
11 Jan 2022
Chief R&D Officer
Sell
4,152
$48.44
$201.12K
Cindy Tahl
11 Jan 2022
General Counsel and Secretary
Sell
536
$49.15
$26.34K
Cindy Tahl
11 Jan 2022
General Counsel and Secretary
Sell
4,883
$48.46
$236.63K
J Scott Wolchko
11 Jan 2022
President and CEO
Sell
4,519
$49.07
$221.75K
J Scott Wolchko
11 Jan 2022
President and CEO
Sell
10,047
$48.50
$487.28K
Bahram Valamehr
10 Jan 2022
Chief R&D Officer
Sell
351
$47.17
$16.56K
Bahram Valamehr
10 Jan 2022
Chief R&D Officer
Sell
5,245
$46.33
$243.00K
Cindy Tahl
10 Jan 2022
General Counsel and Secretary
Sell
643
$47.15
$30.32K
Cindy Tahl
10 Jan 2022
General Counsel and Secretary
Sell
7,095
$46.37
$329.00K
J Scott Wolchko
10 Jan 2022
President and CEO
Sell
101
$47.72
$4.82K
J Scott Wolchko
10 Jan 2022
President and CEO
Sell
20,894
$47.17
$985.57K
J Scott Wolchko
10 Jan 2022
President and CEO
Sell
13,161
$46.36
$610.14K
Edward J Dulac III
19 Aug 2021
Chief Financial Officer
Sell
63
$90.00
$5.67K
Edward J Dulac III
19 Aug 2021
Chief Financial Officer
Sell
1,474
$88.65
$130.67K
Edward J Dulac III
19 Aug 2021
Chief Financial Officer
Sell
1,937
$87.90
$170.26K
Yu-Waye Chu
16 Apr 2021
Senior VP Clinical Development
Sell
1,500
$84.41
$126.62K
Yu-Waye Chu
16 Apr 2021
Senior VP Clinical Development
Sell
900
$82.91
$74.62K
Yu-Waye Chu
16 Apr 2021
Senior VP Clinical Development
Sell
875
$81.80
$71.58K
Daniel D Shoemaker
8 Mar 2021
Chief Scientific Officer
Sell
800
$86.70
$69.36K
Daniel D Shoemaker
8 Mar 2021
Chief Scientific Officer
Sell
2,900
$85.50
$247.96K
Daniel D Shoemaker
8 Mar 2021
Chief Scientific Officer
Sell
2,728
$84.20
$229.70K
Daniel D Shoemaker
8 Mar 2021
Chief Scientific Officer
Sell
2,480
$83.46
$206.99K
Daniel D Shoemaker
8 Mar 2021
Chief Scientific Officer
Sell
2,993
$81.60
$244.22K
Daniel D Shoemaker
8 Mar 2021
Chief Scientific Officer
Sell
5,174
$80.73
$417.72K
Daniel D Shoemaker
8 Mar 2021
Chief Scientific Officer
Sell
4,627
$79.58
$368.24K
Daniel D Shoemaker
8 Mar 2021
Chief Scientific Officer
Sell
3,298
$78.60
$259.24K
Daniel D Shoemaker
11 Jan 2021
Chief Scientific Officer
Sell
871
$109.65
$95.51K
Daniel D Shoemaker
11 Jan 2021
Chief Scientific Officer
Sell
1,050
$110.76
$116.30K
Daniel D Shoemaker
11 Jan 2021
Chief Scientific Officer
Sell
1,332
$111.62
$148.67K
Cindy Tahl
11 Jan 2021
General Counsel and Secretary
Sell
872
$109.65
$95.62K
Cindy Tahl
11 Jan 2021
General Counsel and Secretary
Sell
1,050
$110.76
$116.30K
Cindy Tahl
11 Jan 2021
General Counsel and Secretary
Sell
1,332
$111.62
$148.67K
Bahram Valamehr
11 Jan 2021
Chief Development Officer
Sell
871
$109.65
$95.51K
Bahram Valamehr
11 Jan 2021
Chief Development Officer
Sell
1,051
$110.76
$116.41K
Bahram Valamehr
11 Jan 2021
Chief Development Officer
Sell
1,332
$111.62
$148.67K
J Scott Wolchko
11 Jan 2021
President and CEO
Sell
2,300
$109.65
$252.20K
J Scott Wolchko
11 Jan 2021
President and CEO
Sell
2,772
$110.76
$307.02K
J Scott Wolchko
11 Jan 2021
President and CEO
Sell
3,515
$111.62
$392.33K
Daniel D Shoemaker
8 Jan 2021
Chief Scientific Officer
Sell
151
$114.76
$17.33K
Daniel D Shoemaker
8 Jan 2021
Chief Scientific Officer
Sell
872
$115.80
$100.98K
Daniel D Shoemaker
8 Jan 2021
Chief Scientific Officer
Sell
2,451
$117.15
$287.14K
Daniel D Shoemaker
8 Jan 2021
Chief Scientific Officer
Sell
2,755
$117.60
$323.99K
Cindy Tahl
8 Jan 2021
General Counsel and Secretary
Sell
151
$114.76
$17.33K
Cindy Tahl
8 Jan 2021
General Counsel and Secretary
Sell
872
$115.80
$100.98K
Cindy Tahl
8 Jan 2021
General Counsel and Secretary
Sell
2,451
$117.15
$287.14K
Cindy Tahl
8 Jan 2021
General Counsel and Secretary
Sell
2,755
$117.60
$323.99K
Bahram Valamehr
8 Jan 2021
Chief Development Officer
Sell
151
$114.76
$17.33K
Bahram Valamehr
8 Jan 2021
Chief Development Officer
Sell
872
$115.80
$100.98K
Bahram Valamehr
8 Jan 2021
Chief Development Officer
Sell
2,451
$117.15
$287.14K
Bahram Valamehr
8 Jan 2021
Chief Development Officer
Sell
2,756
$117.60
$324.10K
J Scott Wolchko
8 Jan 2021
President and CEO
Sell
1,469
$114.76
$168.58K
J Scott Wolchko
8 Jan 2021
President and CEO
Sell
8,515
$115.80
$986.03K
J Scott Wolchko
8 Jan 2021
President and CEO
Sell
23,932
$117.15
$2.80M
J Scott Wolchko
8 Jan 2021
President and CEO
Sell
26,904
$117.60
$3.16M
Daniel D Shoemaker
16 Nov 2020
Chief Scientific Officer
Sell
14,781
$52.40
$774.51K
Daniel D Shoemaker
16 Nov 2020
Chief Scientific Officer
Sell
5,287
$51.60
$272.83K
Daniel D Shoemaker
16 Nov 2020
Chief Scientific Officer
Sell
4,932
$50.37
$248.41K
Showing 250 of 388 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 299
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 21
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 155
Sales at will 198
Transactions with no price 0
Shares from compensation/vesting 38,862,198
Sales filed before the plan box existed 178
History held since 7 Oct 2013